Takip et
Javid Moslehi
Javid Moslehi
University of California, San Francisco (UCSF)
ucsf.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis
DY Wang, JE Salem, JV Cohen, S Chandra, C Menzer, F Ye, S Zhao, ...
JAMA oncology 4 (12), 1721-1728, 2018
23642018
Fulminant myocarditis with combination immune checkpoint blockade
DB Johnson, JM Balko, ML Compton, S Chalkias, J Gorham, Y Xu, ...
New England Journal of Medicine 375 (18), 1749-1755, 2016
22092016
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task …
DK Arnett, RS Blumenthal, MA Albert, AB Buroker, ZD Goldberger, ...
Journal of the American College of Cardiology 74 (10), 1376-1414, 2019
20802019
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …
AR Lyon, T Lopez-Fernandez, LS Couch, R Asteggiano, MC Aznar, ...
European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022
19952022
Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging
AP Gomes, NL Price, AJY Ling, JJ Moslehi, MK Montgomery, L Rajman, ...
Cell 155 (7), 1624-1638, 2013
15502013
Telomere dysfunction induces metabolic and mitochondrial compromise
E Sahin, S Colla, M Liesa, J Moslehi, FL Müller, M Guo, M Cooper, ...
Nature 470 (7334), 359-365, 2011
14572011
Myocarditis in patients treated with immune checkpoint inhibitors
SS Mahmood, MG Fradley, JV Cohen, A Nohria, KL Reynolds, ...
Journal of the American College of Cardiology 71 (16), 1755-1764, 2018
14432018
Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline
SH Armenian, C Lacchetti, A Barac, J Carver, LS Constine, N Denduluri, ...
Journal of Clinical Oncology 35 (8), 893-911, 2017
13782017
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ...
The Lancet Oncology 19 (12), 1579-1589, 2018
10252018
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, ...
Annals of Oncology 31 (2), 171-190, 2020
9702020
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
JJ Moslehi, JE Salem, JA Sosman, B Lebrun-Vignes, DB Johnson
The Lancet 391 (10124), 933, 2018
8602018
Immune-checkpoint inhibitors: long-term implications of toxicity
DB Johnson, CA Nebhan, JJ Moslehi, JM Balko
Nature Reviews Clinical Oncology 19 (4), 254-267, 2022
7212022
Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document
E Ammirati, M Frigerio, ED Adler, C Basso, DH Birnie, M Brambatti, ...
Circulation: Heart Failure 13 (11), e007405, 2020
6632020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C …
AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ...
European journal of heart failure 22 (11), 1945-1960, 2020
6472020
Cardiovascular toxic effects of targeted cancer therapies
JJ Moslehi
New England Journal of Medicine 375 (15), 1457-1467, 2016
6312016
Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association
RD Kociol, LT Cooper, JC Fang, JJ Moslehi, PS Pang, MA Sabe, RV Shah, ...
Circulation 141 (6), e69-e92, 2020
5542020
Immune checkpoint inhibitors and cardiovascular toxicity
AR Lyon, N Yousaf, NML Battisti, J Moslehi, J Larkin
The Lancet Oncology 19 (9), e447-e458, 2018
5482018
Tyrosine kinase inhibitor–associated cardiovascular toxicity in chronic myeloid leukemia
JJ Moslehi, M Deininger
Journal of clinical oncology 33 (35), 4210-4218, 2015
4962015
Cardiovascular toxicities associated with immune checkpoint inhibitors
JR Hu, R Florido, EJ Lipson, J Naidoo, R Ardehali, CG Tocchetti, AR Lyon, ...
Cardiovascular research 115 (5), 854-868, 2019
4452019
Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology
MP Bonaca, BA Olenchock, JE Salem, SD Wiviott, S Ederhy, A Cohen, ...
Circulation 140 (1), 80-91, 2019
3912019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20